APP and Alzheimer disease: In another study, Cui et al. [211] used the CNS-specific rabies viral glycoprotein (RVG) to target intravenously infused Exos released from MSCs (MSC-RVG-Exos) to the cerebral cortex and hippocampi of transgenic APP/PS1 AD-model mice.